📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.10.11.511804

Publication URI: http://dx.doi.org/10.1101/2022.10.11.511804

Type: Preprint